Defining the Role of Pharmacists in Polycythemia VeraVideo Categories: Pharmacy
Supported through funding from Incyte
Dr. Boccia compares CancerTYPE ID to other gene expression tests and reviews studies validating its accuracy and clinical utility.
Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.